샘플 요청 목록

 카트 문의
시장보고서
상품코드
1507250

차세대 시퀀싱 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 용도별, 기술별, 제품별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)

Next Generation Sequencing Market Share, Size, Trends, Industry Analysis Report, By Application; By Technology; By Product; By End-Use; By Region; Segment Forecast, 2024 - 2032
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 116 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 차세대 시퀀싱 세계 시장 규모는 2032년까지 434억 2,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

차세대 시퀀싱은 초고처리량, 확장성, 빠른 속도로 전체 게놈의 염기서열을 결정하는 고도로 병렬화된 프로세스이며, DNA 사전 시퀀싱은 일반적인 시퀀싱 프로토콜에서 중요한 단계입니다.

임상 진단에서의 사용 증가, 속도, 비용 효율성, 정확도 향상 등의 요인으로 인해 시장이 성장할 것으로 예상됩니다. 또한, 마이크로어레이와 같은 기존 기술보다 효율성이 향상되고 신약 개발 응용 분야가 증가함에 따라 시장 성장에 기여할 것으로 예상됩니다.

차세대 시퀀서 시장은 경쟁이 치열하며 여러 대기업, 다국적 기업 및 지역 소규모 제조업체가 참여하고 있습니다. 이들 기업은 성능과 환자 결과를 개선하는 혁신적인 스텐트 설계 및 재료를 도입하기 위해 연구 개발 활동에 전념하고 있습니다.

또한, 차세대 염기서열 분석(NGS) 기술이 임상 진단에 널리 사용됨에 따라 시장 확대가 예상됩니다. 이러한 기술의 빠른 응답 시간과 향상된 처리 능력은 시장 성장에 유리한 환경을 조성하고 있습니다.

예를 들어, Pediatrix Medical Group, GeneDx Inc. 및 OPKO Health는 2020년 8월에 첨단 차세대 유전자 시퀀서를 제공하기로 합의했습니다. 이 제휴는 신생아 중환자실에서 희귀 질환의 임상 진단을 강화하는 것을 목표로 하고 있습니다.

차세대 시퀀싱 시장에서는 시퀀싱 기술 기업과 제약 및 바이오 기술 기업과의 제휴 및 인수합병도 증가했습니다. 이러한 제휴는 유전체 데이터를 신약 개발, 개발, 정밀의료 구상의 실현에 활용하기 위한 목적으로 이루어지고 있습니다. 또한, 차세대 시퀀싱 데이터 저장 및 분석을 위한 클라우드 기반 솔루션이 확산되어 연구자들이 대규모 유전체 데이터를 보다 효율적으로 관리하고 분석할 수 있게 되었습니다. 이는 차세대 시퀀싱 플랫폼에서 생성되는 방대한 양의 데이터를 처리하기 위해 데이터 관리 및 생물정보학 솔루션에 대한 관심이 높아진 데 따른 것입니다.

차세대 시퀀싱 시장 보고서 하이라이트

시약 및 소모품 부문은 분자 유전학의 발전과 크기 선택, 표적 농축 및 DNA 단편화를 달성하는 제품 및 키트에 대한 수요 증가로 인해 차세대 시퀀싱 시장에서 가장 큰 매출 점유율을 차지했습니다.

서비스 분야는 SMRT 시퀀싱 기반 기술의 향상과 NGS 데이터 저장을 위한 클라우드 컴퓨팅의 급격한 사용 증가로 인해 예측 기간 동안 가장 빠른 시장 성장을 보였습니다.

2022년 북미는 시퀀싱 플랫폼의 기술 발전과 이 지역의 NGS 응용 분야가 급증하면서 가장 큰 시장 점유율을 차지했습니다. 정부의 적극적인 지원과 암의 급격한 증가도 시장 성장을 촉진할 것입니다.

아시아태평양은 차세대 시퀀서 시장에서 가장 빠른 성장세를 보였습니다. 중국과 인도에서 차세대 시퀀서 연구개발에 대한 투자가 증가하고 있기 때문입니다.

목차

제1장 소개

제2장 주요 요약

제3장 조사 방법

제4장 세계의 차세대 시퀀싱 시장 인사이트

  • 차세대 시퀀싱 - 업계 개요
  • 차세대 시퀀싱 시장 역학
    • 성장 촉진요인과 기회
      • 시퀀싱 기술 향상이 시장 성장을 견인한다
      • 제약회사나 바이오의약품 회사에 의한 차세대 시퀀싱 기술 이용이 증가해 시장의 성장이 촉진될 것으로 생각됩니다.
    • 성장 억제요인과 과제
      • 숙련된 전문가의 부족과 차세대 시퀀싱의 고비용이 시장 성장을 저해할 가능성이 있다
  • PESTLE 분석
  • 차세대 시퀀싱 시장 업계 동향

제5장 세계의 차세대 시퀀싱 시장 평가 : 용도별

  • 주요 조사 결과
  • 소개
  • Drug Discovery·맞춤형 의료
  • 유전자 검사
  • 진단/감염증
  • 농업 및 동물 조사
  • 기타

제6장 세계의 차세대 시퀀싱 시장 : 기술별

  • 주요 조사 결과
  • 소개
  • 전장 유전체
  • 타겟 시퀀싱과 재시퀀싱
  • 전장 엑솜
  • RNA 시퀀싱
  • 칩 시퀀싱
  • 드노보 시퀀싱
  • 메틸 시퀀싱

제7장 세계의 차세대 시퀀싱 시장 : 제품별

  • 주요 조사 결과
  • 소개
  • 기기
  • 시약·소모품
  • 서비스

제8장 차세대 시퀀싱 시장 평가 : 최종 용도별

  • 주요 조사 결과
  • 소개
  • 헬스케어 기관
  • 학술
  • 바이오 기술 및 제약 기업
  • 기타

제9장 차세대 시퀀싱 시장 평가 : 지역별

  • 주요 조사 결과
  • 소개
    • 차세대 시퀀싱 시장 평가 : 지역별, 2019-2032년
  • 북미
    • 북미 : 용도별, 2019-2032년
    • 북미 : 기술별, 2019-2032년
    • 북미 : 제품별, 2019-2032년
    • 북미 : 최종 용도별, 2019-2032년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 용도별,2019-2032
    • 유럽 : 기술별, 2019-2032년
    • 유럽 : 제품별, 2019-2032년
    • 유럽 : 최종 용도별, 2019-2032년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 오스트리아
  • 아시아태평양
    • 아시아태평양 : 용도별, 2019-2032년
    • 아시아태평양 : 기술별, 2019-2032년
    • 아시아태평양 : 제품별, 2019-2032년
    • 아시아태평양 : 최종 용도별, 2019-2032년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
  • 중동 및 아프리카
    • 중동 및 아프리카 : 용도별,2019-2032
    • 중동 및 아프리카 : 기술별, 2019-2032년
    • 중동 및 아프리카 : 제품별, 2019-2032년
    • 중동 및 아프리카 : 최종 용도별, 2019-2032년
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
  • 라틴아메리카
    • 라틴아메리카 : 용도별, 2019-2032년
    • 라틴아메리카 : 기술별, 2019-2032년
    • 라틴아메리카 : 제품별, 2019-2032년
    • 라틴아메리카 : 최종 용도별, 2019-2032년
    • 멕시코
    • 브라질
    • 아르헨티나

제10장 경쟁 상황

  • 확대와 인수 분석
    • 확대
  • 제휴/협업/합의/공개

제11장 기업 개요

  • BGI
  • Bio-Rad Laboratories, Inc.
  • DNASTAR, Inc.
  • Eurofins GATC Biotech GmbH
  • Genomatix GmbH
  • Oxford Nanopore Technologies
  • Perkin Elmer, Inc.
  • PierianDx
  • Qiagen
  • Roche Ltd.
  • Thermo Fisher Scientific Inc.
ksm 24.07.11

The global Next-Generation Sequencing market size is expected to reach USD 43.42 Billion by 2032, according to a new study by Polaris Market Research. The report "Next Generation Sequencing Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery/Personalized Medicine, Genetic Screening, Diagnostics/Infectious Diseases, Agricultural & Animal Research, Others); By Technology; By Product; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Next-generation sequencing is a highly parallelized process characterized by its ultra-high throughput, scalability, and fast rate in determining the sequence of nucleotides across the entire genome. DNA pre-sequencing is a crucial step in the general sequencing protocol because it involves preparing the material for the subsequent sequencing reaction.

The market is anticipated to grow owing to factors such as increased use in clinical diagnosis and improvements in speed, cost-effectiveness, and accuracy. Additionally, the improved efficiency over traditional technologies such as microarrays, combined with an increasing number of drug discovery applications, is expected to contribute to the growth of the market.

The next-generation sequencing market is competitive and includes several major players, multinational corporations, and smaller regional manufacturers. These companies engage in research and development activities to introduce innovative stent designs and materials that improve performance and patient outcomes.

Furthermore, the market is expected to grow as next generation sequencing (NGS) technologies become more widely used in clinical diagnostics. These technologies' quick response times and enhanced processing capabilities create a favorable environment for market growth.

Pediatrix Medical Group, GeneDx Inc., and OPKO Health, for instance, agreed to provide advanced next-gen eration gene sequencing in August 2020. This partnership aims to enhance clinical diagnosis of rare disorders in intensive care units for newborns.

The next-generation sequencing market also witnessed a rise in partnerships and acquisitions between sequencing technology companies and pharmaceutical or biotechnology firms. These collaborations aimed to use genomic data for drug discovery, development, and the realization of precision medicine initiatives. Also, cloud-based solutions for next-generation sequencing data storage and analysis were becoming more popular, allowing researchers to manage and analyze large-scale genomic data more efficiently. It corresponded to the growing emphasis on data management and bioinformatics solutions to deal with the massive amounts of data generated by next-generation sequencing platforms.

Next-Generation Sequencing Market Report Highlights

The reagents and consumables segment held the largest revenue share in the next-generation sequencing market due to an evolution in molecular genetics and an increase in demand for products and kits that accomplish size selection, target enrichment, and DNA fragmentation.

The services segment witnessed the fastest market growth during the forecast period, owing to the improvement in the technology based on SMRT sequencing and a surge in the application of cloud computing for NGS data storage.

In 2022, North America accounted for the largest market share owing to technological advancements in sequencing platforms and the surge in NGS applications in the region. The active support from the government and the surging prevalence of cancer will also drive the market's growth.

Asia Pacific region witnessed the fastest growth in the next generation sequencing market. Due to the increasing investments in China and India in research and development of next generation sequencing.

The global key market players include BGI, Bio-Rad Laboratories, Inc., DNASTAR, Inc., Eurofins GATC Biotech GmbH, Genomatix GmbH, Oxford Nanopore Technologies, PerkinElmer, Inc., PierianDx, Qiagen, Roche Ltd., and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the Next-Generation Sequencing market report based on application, technology, product, end-use, and region.

Next-Generation Sequencing, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Drug Discovery/Personalized Medicine
  • Genetic Screening
  • Diagnostics/Infectious Diseases
  • Agricultural & Animal Research
  • Others

Next-Generation Sequencing, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Whole Genome Sequencing
  • Targeted Sequencing & Re-sequencing
  • Whole Exome Sequencing
  • RNA Sequencing
  • Chip Sequencing
  • De Novo Sequencing
  • Methyl Sequencing

Next-Generation Sequencing, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instruments
  • Reagents & Consumables
  • Services

Next-Generation Sequencing, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Healthcare Institutions
  • Academics
  • Biotech & Pharma Firms
  • Others

Next-Generation Sequencing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Next Generation Sequencing Market Insights

  • 4.1. Next Generation Sequencing - Industry snapshot
  • 4.2. Next Generation Sequencing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Improvements in the sequencing technologies will drive the growth of the market
      • 4.2.1.2. Increasing utilization of next-generation sequencing technology by a pharmaceutical and biopharmaceutical companies will facilitate the growth of the market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of skilled professionals and high cost of next generation sequencing might hinder the growth of the market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Next Generation Sequencing Market Industry trends

5. Global Next Generation Sequencing Market Assessment by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
  • 5.3. Drug Discovery/Personalized Medicine
    • 5.3.1. Global Next Generation Sequencing Market, by Drug Discovery/Personalized Medicine, by Region, 2019 - 2032 (USD Billion)
  • 5.4. Genetic Screening
    • 5.4.1. Global Next Generation Sequencing Market, by Genetic Screening, by Region, 2019 - 2032 (USD Billion)
  • 5.5. Diagnostics/Infectious Diseases
    • 5.5.1. Global Next Generation Sequencing Market, by Diagnostics/Infectious Diseases, by Region, 2019 - 2032 (USD Billion)
  • 5.6. Agricultural & Animal Research
    • 5.6.1. Global Next Generation Sequencing Market, by Agricultural & Animal Research, by Region, 2019 - 2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Next Generation Sequencing Market, by Others, by Region, 2019 - 2032 (USD Billion)

6. Global Next Generation Sequencing Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
  • 6.3. Whole Genome
    • 6.3.1. Global Next Generation Sequencing Market, by Whole Genome, By Region, 2019 - 2032 (USD Billion)
  • 6.4. Targeted Sequencing & Re-sequencing
    • 6.4.1. Global Next Generation Sequencing Market, by Targeted Sequencing & Re-sequencing, by Region, 2019 - 2032 (USD Billion)
  • 6.5. Whole Exome
    • 6.5.1. Global Next Generation Sequencing Market, by Whole Exome, by Region, 2019 - 2032 (USD Billion)
  • 6.6. RNA Sequencing
    • 6.6.1. Global Next Generation Sequencing Market, by RNA Sequencing, by Region, 2019 - 2032 (USD Billion)
  • 6.7. Chip Sequencing
    • 6.7.1. Global Next Generation Sequencing Market, by Chip Sequencing, by Region, 2019 - 2032 (USD Billion)
  • 6.8. De Novo Sequencing
    • 6.8.1. Global Next Generation Sequencing Market, by De Novo Sequencing, by Region, 2019 - 2032 (USD Billion)
  • 6.9. Methyl Sequencing
    • 6.9.1. Global Next Generation Sequencing Market, by Methyl Sequencing, by Region, 2019 - 2032 (USD Billion)

7. Global Next Generation Sequencing Market, by Product

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
  • 7.3. Instruments
    • 7.3.1. Global Next Generation Sequencing Market, by Instruments, By Region, 2019 - 2032 (USD Billion)
  • 7.4. Reagents & Consumables
    • 7.4.1. Global Next Generation Sequencing Market, by Reagents & Consumables, by Region, 2019 - 2032 (USD Billion)
  • 7.5. Services
    • 7.5.1. Global Next Generation Sequencing Market, by Services, by Region, 2019 - 2032 (USD Billion)

8. Next Generation Sequencing Market Assessment by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
  • 8.3. Healthcare Institutions
    • 8.3.1. Global Next Generation Sequencing Market, by Healthcare Institutions, by Region, 2019 - 2032 (USD Billion)
  • 8.4. Academics
    • 8.4.1. Global Next Generation Sequencing Market, by Academics, by Region, 2019 - 2032 (USD Billion)
  • 8.5. Biotech & Pharma Firms
    • 8.5.1. Global Next Generation Sequencing Market, by Biotech & Pharma Firms, by Region, 2019 - 2032 (USD Billion)
  • 8.6. Others
    • 8.6.1. Global Next Generation Sequencing Market, by Others, by Region, 2019 - 2032 (USD Billion)

9. Next Generation Sequencing Market Assessment by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Next Generation Sequencing Market Assessment, By Geography, 2019 - 2032 (USD Billion)
  • 9.3. Next Generation Sequencing Market - North America
    • 9.3.1. North America: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
    • 9.3.2. North America: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
    • 9.3.3. North America: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
    • 9.3.4. North America: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.3.5. Next Generation Sequencing Market - U.S.
      • 9.3.5.1. U.S.: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.3.5.2. U.S.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.3.5.3. U.S.: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.3.5.4. U.S.: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.3.6. Next Generation Sequencing Market - Canada
      • 9.3.6.1. Canada: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.3.6.2. Canada.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.3.6.3. Canada: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.3.6.4. Canada: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
  • 9.4. Next Generation Sequencing Market - Europe
    • 9.4.1. Europe: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
    • 9.4.2. Europe.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
    • 9.4.3. Europe: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
    • 9.4.4. Europe: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.4.5. Next Generation Sequencing Market - UK
      • 9.4.5.1. UK: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.4.5.2. UK.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.4.5.3. UK: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.4.5.4. UK: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.4.6. Next Generation Sequencing Market - France
      • 9.4.6.1. France: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.4.6.2. France.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.4.6.3. France: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.4.6.4. France: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.4.7. Next Generation Sequencing Market - Germany
      • 9.4.7.1. Germany: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.4.7.2. Germany.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.4.7.3. Germany: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.4.7.4. Germany: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.4.8. Next Generation Sequencing Market - Italy
      • 9.4.8.1. Italy: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.4.8.2. Italy.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.4.8.3. Italy: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.4.8.4. Italy: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.4.9. Next Generation Sequencing Market - Spain
      • 9.4.9.1. Spain: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.4.9.2. Spain.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.4.9.3. Spain: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.4.9.4. Spain: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.4.10. Next Generation Sequencing Market - Netherlands
      • 9.4.10.1. Netherlands: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.4.10.2. Netherlands.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.4.10.3. Netherlands: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.4.10.4. Netherlands: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.4.11. Next Generation Sequencing Market - Austria
      • 9.4.11.1. Austria: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.4.11.2. Austria.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.4.11.3. Austria: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.4.11.4. Austria: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
  • 9.5. Next Generation Sequencing Market - Asia-Pacific
    • 9.5.1. Asia Pacific: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
    • 9.5.2. Asia Pacific.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
    • 9.5.3. Asia-pacific: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
    • 9.5.4. Asia-pacific: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.5.5. Next Generation Sequencing Market - China
      • 9.5.5.1. China: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.5.5.2. China.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.5.5.3. China: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.5.5.4. China: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.5.6. Next Generation Sequencing Market - India
      • 9.5.6.1. India: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.5.6.2. India.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.5.6.3. India: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.5.6.4. India: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.5.7. Next Generation Sequencing Market - Malaysia
      • 9.5.7.1. Malaysia: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.5.7.2. Malaysia.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.5.7.3. Malaysia: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.5.7.4. Malaysia: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.5.8. Next Generation Sequencing Market - Japan
      • 9.5.8.1. Japan: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.5.8.2. Japan.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.5.8.3. Japan: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.5.8.4. Japan: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.5.9. Next Generation Sequencing Market - Indonesia
      • 9.5.9.1. Indonesia: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.5.9.3. Indonesia: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.5.9.4. Indonesia: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.5.10. Next Generation Sequencing Market - South Korea
      • 9.5.10.1. South Korea: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.5.10.2. South Korea.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.5.10.3. South Korea: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.5.10.4. South Korea: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
  • 9.6. Next Generation Sequencing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
    • 9.6.2. Middle East & Africa.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.6.5. Next Generation Sequencing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.6.6. Next Generation Sequencing Market - UAE
      • 9.6.6.1. UAE: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.6.6.2. UAE.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.6.6.3. UAE: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.6.6.4. UAE: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.6.7. Next Generation Sequencing Market - Israel
      • 9.6.7.1. Israel: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.6.7.2. Israel.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.6.7.3. Israel: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.6.7.4. Israel: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.6.8. Next Generation Sequencing Market - South Africa
      • 9.6.8.1. South Africa: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.6.8.2. South Africa.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.6.8.3. South Africa: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.6.8.4. South Africa: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
  • 9.7. Next Generation Sequencing Market - Latin America
    • 9.7.1. Latin America: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
    • 9.7.2. Latin America.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
    • 9.7.3. Latin America: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
    • 9.7.4. Latin America: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.7.5. Next Generation Sequencing Market - Mexico
      • 9.7.5.1. Mexico: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.7.5.2. Mexico.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.7.5.3. Mexico: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.7.5.4. Mexico: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.7.6. Next Generation Sequencing Market - Brazil
      • 9.7.6.1. Brazil: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.7.6.2. Brazil.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.7.6.3. Brazil: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.7.6.4. Brazil: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)
    • 9.7.7. Next Generation Sequencing Market - Argentina
      • 9.7.7.1. Argentina: Next Generation Sequencing Market, By Application, 2019 - 2032 (USD Billion)
      • 9.7.7.2. Argentina.: Next Generation Sequencing Market, By Technology, 2019 - 2032 (USD Billion)
      • 9.7.7.3. Argentina: Next Generation Sequencing Market, By Product, 2019 - 2032 (USD Billion)
      • 9.7.7.4. Argentina: Next Generation Sequencing Market, By End Use, 2019 - 2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. BGI
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Bio-Rad Laboratories, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. DNASTAR, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Eurofins GATC Biotech GmbH
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Genomatix GmbH
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Oxford Nanopore Technologies
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Perkin Elmer, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. PierianDx
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Qiagen
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Roche Ltd.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Thermo Fisher Scientific Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제